SLT in the Glaucoma Treatment Armamentarium - Video Interview with Roberto Cararssa, MD, Italy

SLT in the Glaucoma Treatment Armamentarium

Video Interview with Roberto Cararssa, MD, Italy

Long-term control of intraocular pressure (IOP) is key to minimizing the ocular damage that eventually occurs in glaucoma patients. The effects of traditional anti-glaucoma eyedrops are short-lived and therefore require diligent, long-term use. Even argon laser trabeculoplasty (ALT), which is known to deliver effective results, starts to lose efficacy within several years. In contrast, selective laser trabeculoplasty (SLT) delivers effective IOP reduction that lasts far longer than any other treatment. Watch the video interview with Dr. Carassa to learn more.